OTESECONAZOLE - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for oteseconazole and what is the scope of patent protection?
Oteseconazole
is the generic ingredient in one branded drug marketed by Mycovia Pharms and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.Oteseconazole has sixty-three patent family members in twenty-two countries.
One supplier is listed for this compound.
Summary for OTESECONAZOLE
| International Patents: | 63 |
| US Patents: | 5 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 25 |
| Patent Applications: | 50 |
| What excipients (inactive ingredients) are in OTESECONAZOLE? | OTESECONAZOLE excipients list |
| DailyMed Link: | OTESECONAZOLE at DailyMed |
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for OTESECONAZOLE
Generic Entry Date for OTESECONAZOLE*:
Constraining patent/regulatory exclusivity:
Dosage:
CAPSULE;ORAL |
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
US Patents and Regulatory Information for OTESECONAZOLE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Mycovia Pharms | VIVJOA | oteseconazole | CAPSULE;ORAL | 215888-001 | Apr 26, 2022 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for OTESECONAZOLE
| Country | Patent Number | Title | Estimated Expiration |
|---|---|---|---|
| Japan | 2013177409 | METALLOENZYME INHIBITOR COMPOUND | ⤷ Try a Trial |
| Poland | 2804858 | ⤷ Try a Trial | |
| Canada | 2837400 | COMPOSES 5 (PHENYLE EVENTUELLEMENT SUBSTITUE) PYRIDINE 2 YL EN TANT QU'INHIBITEURS DE METALLOENZYME (5-(OPTIONALLY SUBSTITUTED PHENYL) PYRIDIN-2-YL COMPOUNDS AS METALLOENZYME INHIBITORS) | ⤷ Try a Trial |
| Slovenia | 3271347 | ⤷ Try a Trial | |
| Serbia | 63566 | ANTIFUNGALNA JEDINJENJA I PROCESI IZRADE (ANTIFUNGAL COMPOUNDS AND PROCESSES FOR MAKING) | ⤷ Try a Trial |
| Eurasian Patent Organization | 037556 | ПОЛИМОРФНЫЕ ФОРМЫ ПРОТИВОГРИБКОВЫХ СОЕДИНЕНИЙ И СПОСОБЫ ИХ ПОЛУЧЕНИЯ (POLYMORPHIC FORMS OF ANTIFUNGAL COMPOUNDS AND PROCESSES FOR MAKING SAME) | ⤷ Try a Trial |
| >Country | >Patent Number | >Title | >Estimated Expiration |
